Ecallantide for treatment of acute hereditary angioedema attacks: Analysis of efficacy by patient characteristics

By MacGinnitie Andrew J.   Campion Marilyn   Stolz Leslie E.   Pullman William E.  

Allergy and Asthma Proceedings, Vol. 33, Iss. 2, 2012-03 ,pp. : 178-185

OceanSide Publications, Inc

Access to resources Recommend Favorite

Facilitating home-based treatment of hereditary angioedema

By  

Allergy and Asthma Proceedings, Vol. 36, Iss. 2, 2015-03 ,pp. : 92-99

OceanSide Publications, Inc

Access to resources Recommend Favorite

Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations

By Gower Richard G.   Lumry William R.   Davis-Lorton Mark A.   Johnston Douglas T.   Busse Paula J.  

Allergy and Asthma Proceedings, Vol. 33, Iss. 3, 2012-05 ,pp. : 235-240

OceanSide Publications, Inc

Access to resources Recommend Favorite

Home treatment of attacks with conestat alfa in hereditary angioedema due to C1-inhibitor deficiency

By Farkas Henriette   Csuka Dorottya   Veszeli Nóra   Zotter Zsuzsanna   Szabó Erika   Varga Lilian  

Allergy and Asthma Proceedings, Vol. 35, Iss. 3, 2014-05 ,pp. : 255-259

OceanSide Publications, Inc

Access to resources Recommend Favorite

Response to ecallantide treatment of acute attacks of hereditary angioedema based on time to intervention: Results from the EDEMA clinical trials

By Banta Erin   Horn Patrick   Craig Timothy J.  

Allergy and Asthma Proceedings, Vol. 32, Iss. 4, 2011-07 ,pp. : 319-324

OceanSide Publications, Inc

Access to resources Recommend Favorite